Stay updated on XEN801 Topical Gel Clinical Trial
Sign up to get notified when there's something new on the XEN801 Topical Gel Clinical Trial page.

Latest updates to the XEN801 Topical Gel Clinical Trial page
- Check7 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.3%
- Check14 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and the removal of specific location details, including the full address of Montreal, Quebec, Canada.SummaryDifference2%
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%
- Check36 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check43 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1%
- Check50 days agoChange DetectedThe web page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.SummaryDifference0.3%
Stay in the know with updates to XEN801 Topical Gel Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XEN801 Topical Gel Clinical Trial page.